These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 16430886)
1. Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics. Mottier L; Alvarez L; Ceballos L; Lanusse C Exp Parasitol; 2006 May; 113(1):49-57. PubMed ID: 16430886 [TBL] [Abstract][Full Text] [Related]
2. Transtegumental diffusion of benzimidazole anthelmintics into Moniezia benedeni: correlation with their octanol-water partition coefficients. Mottier ML; Alvarez LI; Pis MA; Lanusse CE Exp Parasitol; 2003; 103(1-2):1-7. PubMed ID: 12810040 [TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of the access of albendazole, fenbendazole and triclabendazole to Fasciola hepatica: effect of bile in the incubation medium. Alvarez LI; Mottier ML; Lanusse CE Parasitology; 2004 Jan; 128(Pt 1):73-81. PubMed ID: 15002906 [TBL] [Abstract][Full Text] [Related]
4. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect. Mottier L; Alvarez L; Fairweather I; Lanusse C J Parasitol; 2006 Dec; 92(6):1355-60. PubMed ID: 17304820 [TBL] [Abstract][Full Text] [Related]
5. Measurement of triclabendazole and its metabolites in liver flukes: method development and full validation. Mottier L; Moreno L; Alvarez L; Virkel G; Lanusse C J Pharm Biomed Anal; 2004 Sep; 35(5):991-9. PubMed ID: 15336346 [TBL] [Abstract][Full Text] [Related]
6. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes. Alvarez LI; Solana HD; Mottier ML; Virkel GL; Fairweather I; Lanusse CE Parasitology; 2005 Oct; 131(Pt 4):501-10. PubMed ID: 16174415 [TBL] [Abstract][Full Text] [Related]
7. Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep. Moreno L; Ceballos L; Fairweather I; Lanusse C; Alvarez L Exp Parasitol; 2014 Jan; 136():14-9. PubMed ID: 24211244 [TBL] [Abstract][Full Text] [Related]
8. Enantioselective binding of albendazole sulphoxide to cytosolic proteins from helminth parasites. Solana HD; Sallovitz JM; Lanusse CE; Rodriguez JA Methods Find Exp Clin Pharmacol; 2002; 24(1):7-13. PubMed ID: 11980387 [TBL] [Abstract][Full Text] [Related]
9. Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites. Solana HD; Rodriguez JA; Lanusse CE Parasitol Res; 2001 Apr; 87(4):275-80. PubMed ID: 11355675 [TBL] [Abstract][Full Text] [Related]
10. Drug transfer into target helminth parasites. Alvarez LI; Mottier ML; Lanusse CE Trends Parasitol; 2007 Mar; 23(3):97-104. PubMed ID: 17236810 [TBL] [Abstract][Full Text] [Related]
11. Ex vivo diffusion of albendazole and its sulfoxide metabolite into ascaris suum and Fasciola hepatica. Alvarez LI; Mottier ML; Sánchez SF; Lanusse CE Parasitol Res; 2001 Nov; 87(11):929-34. PubMed ID: 11728018 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep. Virkel G; Lifschitz A; Sallovitz J; Pis A; Lanusse C J Vet Pharmacol Ther; 2006 Jun; 29(3):213-23. PubMed ID: 16669866 [TBL] [Abstract][Full Text] [Related]
13. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica. Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238 [TBL] [Abstract][Full Text] [Related]
14. Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica. Mottier L; Virkel G; Solana H; Alvarez L; Salles J; Lanusse C Xenobiotica; 2004; 34(11-12):1043-57. PubMed ID: 15801547 [TBL] [Abstract][Full Text] [Related]
15. Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion ability. Moreno L; Alvarez L; Mottier L; Virkel G; Bruni SS; Lanusse C J Vet Pharmacol Ther; 2004 Oct; 27(5):299-308. PubMed ID: 15500567 [TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs. Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276 [TBL] [Abstract][Full Text] [Related]
17. A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica. Toner E; McConvery F; Brennan GP; Meaney M; Fairweather I Parasitology; 2009 Apr; 136(5):523-35. PubMed ID: 19272211 [TBL] [Abstract][Full Text] [Related]
18. Understanding the main route of drug entry in adult Fasciola hepatica: Further insights into closantel pharmacological activity. Ceballos L; Canton C; Cadenazzi G; Larsen K; Virkel G; Moreno L; Fairweather I; Lanusse C; Alvarez L Exp Parasitol; 2017 Oct; 181():23-29. PubMed ID: 28734749 [TBL] [Abstract][Full Text] [Related]
19. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Robinson MW; Lawson J; Trudgett A; Hoey EM; Fairweather I Parasitol Res; 2004 Feb; 92(3):205-10. PubMed ID: 14652740 [TBL] [Abstract][Full Text] [Related]
20. A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica. Toner E; Brennan GP; McConvery F; Meaney M; Fairweather I Parasitology; 2010 Apr; 137(5):855-70. PubMed ID: 20030907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]